Sarepta Therapeutics (Nasdaq: SRPT) announced Henri Termeer, industry leader and former CEO of Genzyme, will be a key advisor to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE